Feature | December 17, 2013

United States Ranks Near Bottom Among Industrialized Nations in Healthcare Spending Efficiency

UCLA, McGill study also shows women fare worse than men in most countries

December 17, 2013 — A new study by researchers at the University of California, Los Angeles (UCLA) Fielding School of Public Health and McGill University in Montréal reveals that the United States healthcare system ranks 22nd out of 27 high-income nations when analyzed for its efficiency of turning dollars spent into extending lives.
 
The study, which appears in the "First Look" section of the American Journal of Public Health, illuminates stark differences in countries' efficiency of spending on healthcare, and the United States' inferior ranking reflects a high price paid and a low return on investment.
 
For example, every additional $100 spent on healthcare by the United States translated into a gain of less than half a month of life expectancy. In Germany, every additional $100 spent translated into more than four months of increased life expectancy. The researchers also discovered significant gender disparities within countries.
 
"Out of the 27 high-income nations we studied, the United States ranks 25th when it comes to reducing women's deaths," said Jody Heymann, M.D., Ph.D., dean, UCLA Fielding School of Public Health, and senior author of the study. "The country's efficiency of investments in reducing men's deaths is only slightly better, ranking 18th."
 
The study, which utilized data from 27 member countries of the Organization for Economic Cooperation and Development collected over 17 years (1991–2007), is the first known research to estimate health-spending efficiency by gender across industrialized nations.
 
"While there are large differences in the efficiency of health spending across countries, men have experienced greater life expectancy gains than women per health dollar spent within nearly every country," said Douglas Barthold, the study's first author and doctoral candidate, department of economics, McGill University.
 
The report's findings bring to light several questions. How is it possible for the United States to have one of the most advanced economies yet one of the most inefficient healthcare systems? And while the United States healthcare system is performing so poorly for men, why is it performing even worse for women?
 
The exact causes of the gender gap are unknown, the researchers said, thus highlighting the need for additional research on the topic, but the nation's lack of investment in prevention for both men and women warrants attention.
 
"The most effective way to stop people from dying prematurely is to prevent them from getting sick in the first place," said Heymann.
 
Last year, the United States spent only a fraction of its $2.65 trillion annual healthcare budget on prevention. Healthcare spending is a large and ever-increasing portion of government budgets, particularly in the United States. Therefore, allocating the necessary resources for prevention and improving overall efficiency are both critically important to preventing premature deaths and wiser spending, the researchers stressed.
 
Additional authors included assistant professor Arijit Nandi and researcher José Mauricio Mendoza Rodríguez of McGill University.
 
For more information: www.apha.com

Related Content

News | Pharmaceuticals| September 26, 2016
Nearly 2 out of 5 people with diabetes who could benefit from statin therapy to lower their risk of future heart attack...
smartphones, hospital tranfers, heart attack patients, JACC study, South Korea
News | Mobile Devices| September 23, 2016
Smartphone communication among medical teams at different hospitals can significantly reduce the time it takes for...
Medtronic, In.Pact Admiral drug-coated balloon, trial data, VIVA
News | Drug-Eluting Balloons| September 22, 2016
New data presented at the Vascular Interventional Advances (VIVA) conference demonstrated the durability, consistency...
Medtronic, CRT, cardiac resynchroniazation therapy devices, heart failure, medication adherence, retrospective analysis, HFSA 2016
News | Heart Failure| September 20, 2016
Medtronic plc announced the results of an analysis that reveals patients increasingly adhere to heart failure...
Valtech Cardio, Cardioband Tricuspid, Cardioband Mitral, PCR London Valves 2016, study data
News | Heart Valve Technology| September 19, 2016
Valtech Cardio Ltd. announced that it will present the first-in-man data for its Cardioband Tricuspid (TR) system at...
EBR Systems, FDA, WiSE Technology, Wireless Stimulation Endocardially, SOLVE-CRT study

The WiSE CRT System uses a tiny implant in the left ventricle to synchronize the heart, overcoming limitations of traditional cardiac resynchronization therapy (CRT) in heart failure patients. Graphic courtesy of Business Wire.

News | Cardiac Resynchronization Therapy Devices (CRT)| September 15, 2016
EBR Systems Inc. announced the U.S. Food and Drug Administration (FDA) has granted an Investigational Device Exemption...
News | Cardiac Diagnostics| September 13, 2016
September 13, 2016 — Results from a new study suggest that small molecules known as microRNAs may be part of the path
News | Cardiac Diagnostics| September 13, 2016
September 13, 2016 — Findings from a small...
News | Cardiac Diagnostics| September 12, 2016
A Saint Louis University researcher has received a grant to study the effects of treating post-traumatic stress...
congenital heart defects, CHD, risk factors, genes, University of California Irvine research
News | Congenital Heart| September 09, 2016
September 9, 2016 — New research published Sept.
Overlay Init